|
Clinical use of RNA sequencing and oncobox analytics to predict personalized targeted therapeutic efficacy. |
|
|
|
|
Stock and Other Ownership Interests - Vitamed |
|
|
No Relationships to Disclose |
|
|
Employment - OmicsWay Corporation |
Leadership - OmicsWay Corporation |
Stock and Other Ownership Interests - OmicsWay Corporation |
|
|
Employment - OmicsWay Corporation |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - OrthoCentrum Hamburg (I) |
|
|
No Relationships to Disclose |
|
|
Employment - OmicsWay Corporation |
Leadership - OmicsWay Corporation |
Stock and Other Ownership Interests - OmicsWay Corporation |
|
|
Employment - Ortho Centrum Hamburg |
Patents, Royalties, Other Intellectual Property - Patents on medical devices (Inst) |
|
|
No Relationships to Disclose |
|
|
Employment - OmicsWay Corporation |
Stock and Other Ownership Interests - OmicsWay Corporation |
|
|
Employment - OmicsWay Corporation |
Leadership - OmicsWay Corporation |
Stock and Other Ownership Interests - OmicsWay Corporation |